Vascular endothelium plays a key role in directing pulmonary epithelial cell differentiation. by Yao, Jiayi et al.
UCLA
UCLA Previously Published Works
Title
Vascular endothelium plays a key role in directing pulmonary epithelial cell differentiation.
Permalink
https://escholarship.org/uc/item/1mn4z44g
Journal
The Journal of cell biology, 216(10)
ISSN
0021-9525
Authors
Yao, Jiayi
Guihard, Pierre J
Wu, Xiuju
et al.
Publication Date
2017-10-01
DOI
10.1083/jcb.201612122
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
JCB
JCB: Article
T
H
E
 J
O
U
R
N
A
L
 O
F
 C
E
L
L
 B
IO
L
O
G
Y
3369
The Rockefeller University Press 
J. Cell Biol. Vol. 216 No. 10 3369–3385
https://doi.org/10.1083/jcb.201612122
Introduction
In recent years, several studies have demonstrated the import-
ant role of vascular endothelium in endothelial–epithelial in-
teractions during the developmental process (Matsumoto et al., 
2001; Ding et al., 2010, 2011; Lee et al., 2014). Endothelial 
cells (ECs) direct proliferation and differentiation of epithelial 
cells (Lee et al., 2014), whereas epithelial cells stimulate ECs to 
proliferate and form blood vessels. Indeed, inductive effects of 
ECs on epithelial differentiation have been identified during the 
development of lungs, liver, heart, pancreas, stomach, and bone 
(Matsumoto et al., 2001; Ding et al., 2010, 2011; Kusumbe et 
al., 2014), and the absence of ECs results in defective develop-
ment of the liver bud (Matsumoto et al., 2001).
The pulmonary vasculature exhibits unique characteristics 
to allow for gas exchange. The pulmonary endothelium coordi-
nates with the epithelium to form alveolar units, where cell–cell 
contact facilitates the endothelial–epithelial interactions in the 
peripheral respiratory system. Pulmonary ECs have been shown 
to not only support pulmonary epithelial cells, but also to guide 
the differentiation and maturation of epithelial cells (Ding et 
al., 2011). The absence of ECs results in incomplete induction 
of pulmonary lineages in pulmonary progenitor cells (Lee et al., 
2014), and endothelial defects may impair epithelial repair after 
lung injury (Lee et al., 2014).
Matrix Gla protein (MGP), a bone morphogenetic pro-
tein (BMP) antagonist (Zebboudj et al., 2002; Yao et al., 2008, 
2011), is best known for its ability to prevent calcification in 
elastic arteries (Luo et al., 1997; Speer et al., 2009) but is also 
highly expressed in pulmonary epithelial cells (Gilbert and 
Rannels, 2004; Yao et al., 2007, 2011). Excessive MGP in mice 
inhibits pulmonary vascular growth by limiting BMP activity 
and VEGF expression (Yao et al., 2007, 2011), and mutations 
in the human Mgp gene, known as the Keutel syndrome, cause 
peripheral pulmonary stenosis and other developmental defects 
(Meier et al., 2001). We previously demonstrated that deletion 
of the Mgp gene in mice causes an imbalance between the pul-
monary vasculature and the airways, leading to vascular over-
growth with arteriovenous malformation and underdeveloped 
airways (Yao et al., 2011). Furthermore, MGP is necessary to 
ensure normal endothelial differentiation in progenitor cells 
(Yao et al., 2016) and prevent arterial ECs from undergoing 
endothelial–mesenchymal transitions (Yao et al., 2013a, 2015).
We now report that MGP is essential for endothelial– 
epithelial interactions to direct pulmonary specification. The 
absence of MGP disrupts such interactions and triggers hepatic 
differentiation in the pulmonary epithelium as mediated by the 
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endothelium. Our results highlight the importance of the cross 
talk between endothelium and epithelium in pulmonary speci-
fication and suggest that timely MGP expression is essential to 
suppress hepatic differentiation in the lungs. It also explains the 
near absence of MGP expression in the liver.
Results
Hepatic differentiation in Mgp−/− lungs
Because multiple organs in Mgp−/− mice have highly abnor-
mal phenotypes (Yao et al., 2007, 2011, 2013a,b), we analyzed 
the global gene expression profiles derived from different or-
gans in these mice. Unexpectedly, we found that the lung pro-
file clustered closely with that of the liver (Fig.  1  a). In the 
Mgp−/− lungs, gene expression involved in the metabolism of 
fat, glucose and cholesterol, cytochromes, xenobiotics, and he-
patic enzymes was similar to that of Mgp−/− and Mgp+/+ liver 
(Fig. 1 b). We confirmed these changes in the early hepatocyte 
markers albumin, GATA-binding protein 4 (Gata4), forkhead 
box A3 (Foxa3), HNF1 homeobox A (Hnf1a), hepatocyte nu-
clear factor 4 α (Hnf4a), α-fetoprotein (AFP), the hematopoi-
etically expressed homeobox (Hex), and hepatic growth factor 
(HGF), as well as the mature hepatocyte markers transthyretin 
(Ttr), phenylalanine hydroxylase (Pah), and apolipoproteins 
(Fig. 1, c and d; and Fig. S1 a). The results showed that all of 
these markers were induced in the Mgp−/− lungs. In addition, 
high levels of albumin protein (Fig. 1 e) and cytochrome P450 
activity (Fig. 1 f), which are normal findings in liver (Sekiya and 
Suzuki, 2011), were observed in isolated Mgp−/− lung cells. As 
might be expected, disordered alveolar structure with abnormal 
cell mixtures was detected in the Mgp−/− lungs by transmission 
EM (Fig. S1 b). Together, the results suggest the occurrence 
of ectopic hepatic differentiation in Mgp−/− lungs. Expression 
of MGP in normal liver is extremely low, and no significant 
changes in expression profiles or hepatocytes were detected in 
Mgp−/− liver as compared with normal liver (Fig. 1 a; Luo et al., 
1997). We did not detect any induction of pulmonary markers 
in the livers of Mgptg/wt mice (Fig. S2), in which excess human 
MGP was expressed (Yao et al., 2007). However, gene expres-
sion associated with lung function differed between Mgp−/− and 
Mgp+/+ lungs (Fig. 1 b), consistent with our previous findings 
(Yao et al., 2007, 2011). Pathological examination excluded tu-
morigenesis in all of the examined Mgp−/− lungs.
We performed lineage tracing to further investigate the 
hepatic differentiation in Mgp−/− lungs. We traced albumin ex-
pression in the lungs of Mgp−/− and Mgp+/+ mice using AlbCre 
RosaLacZ and AlbCreRosaEGfp transgenic mice, where Cre-activated 
expression of β-galactosidase or EGFP is driven by the albumin 
promoter (Fig. 1, g and h; Postic et al., 1999; Soriano, 1999; 
Ballarín-González et al., 2013). We observed high pulmonary 
expression of β-galactosidase in AlbCreRosaLacZMgp−/− mice at 
4 wk of age (Fig. 1 h) and EGFP in AlbCreRosaEGfpMgp−/− mice 
on embryonic day (E) 13.5 and postnatal day (P) 28 (Fig. 1  i 
and Fig. S3). The expression of EGFP was confirmed by flow 
cytometric analysis (Fig. 1 j).
We examined the pulmonary function of Mgp−/− mice 
by unrestricted whole body barometric plethysmography. We 
found that the respiratory rate of Mgp−/− mice was >1.5-fold 
higher than that of WT mice during room air breathing and in 
the hypercapnia phase, whereas no significant difference in tidal 
volume was detected between Mgp−/− and WT mice. We found 
a significant increase of peak expiratory and inspiratory flow 
and minute ventilation in Mgp−/− mice during room air breath-
ing. Together, the data suggested the increased respiration in 
Mgp−/− mice (Fig. 1 k). We also examined the expression of the 
pulmonary marker NK2 homeobox 1 (Nkx2.1), the type I pul-
monary epithelial marker aquaporin 5 (Aqp5), the type II pul-
monary epithelial marker surfactant-associated protein B and C 
(Spb and Spc), and the Clara cell marker of Clara cell secretory 
protein (CCSP) using real-time PCR. The result showed a sig-
nificant decrease in CCSP in Mgp−/− lungs (Fig. 1 l), suggesting 
a disruption of epithelial cell differentiation. Our previous study 
showed no difference in arterial oxygen levels between Mgp−/− 
and WT mice (Yao et al., 2013b). We argue that the enhanced 
respiration in Mgp−/− mice compensates for the inefficiency of 
gas exchange caused by abnormal epithelial cell differentiation.
We also examined albumin expression in organs with 
variable levels of MGP expression (Yao et al., 2007) includ-
ing lungs, artery, brain, kidneys, bone, heart, muscle, and 
liver. The albumin expression was only increased in the 
Mgp−/− lungs (Fig. 1 m).
Hepatic differentiation in Mgp−/− airway 
progenitors
To understand how hepatic differentiation occurs in Mgp−/− 
lungs, we first identified MGP in the epithelium of embryonic 
lungs from E12.5 to E18.5 by immunofluorescence (Fig. 2 a). 
To determine what cells were responsible for the MGP expres-
sion, we separated pulmonary ECs and epithelial cells using 
flow cytometry with antibodies recognizing the endothelial 
marker CD31 and examined MGP expression by real-time 
PCR. The results revealed that MGP expression was signifi-
cantly higher in the CD31− pulmonary cells than in the CD31+ 
pulmonary ECs (Fig. 2 b). Furthermore, in Mgp−/− lungs, the 
hepatic markers Foxa3, Gata4, Hnf4a, albumin, and c-Met 
were all increased in the CD31− cell population, whereas 
HGF and Flt1 were abnormally induced in the CD31+ ECs 
(Fig.  2  c). No MGP was detected in the liver of Mgp+/+ or 
Mgp−/− mice (Fig. 2, b–d).
To further investigate whether hepatic differentiation oc-
curred in Mgp−/− pulmonary cells, we successfully isolated a 
large population of cells that expressed albumin and AFP from 
P28 Mgp−/− lungs by flow cytometry (Fig. 3 a). We examined 
hepatic, pulmonary epithelial, and endothelial markers by real- 
time PCR. The hepatocyte markers Ttr, Foxa3, and Hnf4a were 
highly induced in these cells, as well as the pulmonary epithelial 
markers Nkx2.1, Aqp5, and CCSP and Spb, Spc, and Spd. How-
ever, no significant expression of the endothelial markers Flk1, 
vascular endothelial (VE)–cadherin, and CD31 was detected 
(Fig. 3 b), suggesting that hepatic differentiation occurred only 
in the Mgp−/− pulmonary epithelial cells.
To determine which pulmonary cell lineage expressed 
the hepatic markers, we first costained albumin with the airway 
progenitor markers Sox9 and Foxp2 (Mou et al., 2012) in E12.5 
embryonic lungs from Mgp+/+ and Mgp−/− mice. The results 
revealed that albumin was expressed in the Sox9+Foxp2+ air-
way progenitors in Mgp−/− lungs (Fig. 3 c). We then determined 
whether albumin was expressed in cells normally derived from 
these progenitors by costaining albumin and pulmonary epithe-
lial cell markers in P28 Mgp−/− lungs: Spb for type II epithe-
lial cells, Aqp5 for type I epithelial cells, and CCSP for Clara 
cells. We found that albumin colocalized with all three markers 
(Fig. 3 d), suggesting that hepatic differentiation was triggered 
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Figure 1. Hepatic differentiation in the lungs of Mgp−/− mice. (a) Gene expression profiles from lungs and liver of WT (Mgp+/+) and Mgp−/− mice (n = 
2). (b) Genes involved in liver metabolism with extraction of significant difference in expression (P < 0.05). (c and d) Expression of select hepatic markers 
was analyzed by real-time PCR. The difference in expression was calculated as a fold change as compared between Mgp+/+ and Mgp−/− lungs (n = 10). 
(e and f) Albumin levels (e) and activity of P450 (f) were compared in cells isolated from Mgp+/+ and Mgp−/− lungs. Isolated hepatocytes from Mgp+/+ and 
Mgp−/− liver were used as controls (n = 8). (g) Schematic diagram of strategy for detecting albumin promoter–driven expression of β-galactosidase (LacZ) 
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early in airway progenitor cells and maintained in Mgp−/− pul-
monary epithelium (Fig. 3 e).
Interestingly, expression of HGF was significantly higher 
in the albumin and AFP-negative cells (Fig. 3 b), supporting that 
HGF was induced in Mgp−/− pulmonary ECs. For validation, we 
costained HGF and the early endothelial marker CD34 in Mgp−/− 
lung from E12.5 to E18.5 and found colocalization of HGF with 
CD34 (Fig. 4 a), but not with Nkx2.1 (Fig. 4 b). These results 
confirmed the induction of HGF in Mgp−/− pulmonary ECs.
Endothelial-specific gene deletion of 
Hgf decreases hepatic differentiation in 
Mgp−/− lungs
To determine the role of endothelial HGF in the ectopic dif-
ferentiation in Mgp−/− lungs, we used Cdh5Cre mice where 
Cdh5 (VE-cadherin) promoter–driven Cre is expressed in ECs 
(Alva et al., 2006). We crossbred Cdh5Cre and Hgf flox/flox mice 
with Mgp+/− mice to obtain Chd5CreHgf flox/floxMgp−/− mice with 
EC-specific deletion of Hgf (Fig. 5 a). The mice still exhibited 
the Mgp−/− phenotype with vascular calcification as previously 
described (Luo et al., 1997; Yao et al., 2011, 2013b), suggesting 
that depletion of HGF had no additional effect on the vasculature.
We then examined the expression of genes related to 
metabolism of fat, glucose and cholesterol, cytochromes, xe-
nobiotic metabolism, and hepatic enzymes. We found that the 
similarities in expression between lungs and liver were sig-
nificantly reduced in Chd5CreHgfflox/floxMgp−/− mice (Fig. 5 b). 
Furthermore, we examined the expression of the hepatocyte 
markers albumin, Ttr, Pah, and AFP, the activity of cytochrome 
P450, and the protein levels of albumin in lungs. Compared 
with the Mgp−/− lungs, all of these parameters were reduced 
in the lungs of Chd5CreHgfflox/floxMgp−/− mice (Fig. 5, c and d), 
suggesting that depletion of endothelial HGF limited ectopic 
hepatic differentiation in Mgp−/− lungs.
VEGF and Flt1 induces endothelial HGF in 
Mgp−/− lungs
Our previous studies showed that increased BMP signaling, 
specifically involving BMP-4, affected pulmonary vascular-
ization and alveolar development in Mgp−/− mice (Yao et al., 
2007, 2011). To determine whether dysregulated endothelial–
epithelial interactions caused by MGP deficiency induced HGF, 
we isolated Mgp+/+ and Mgp−/− pulmonary epithelial cells and 
ECs and treated them with 40 ng/ml BMP-4 for 24 h. In Mgp−/− 
epithelial cells, BMP-4 enhanced the induction of VEGF and 
c-Met (Fig. 6 a, control), whereas in Mgp−/− ECs, BMP-4 en-
hanced the induction of Flt1 and HGF (Fig. 6 b, control). We 
then transfected both cell types with Flt1 siRNA or treated the 
cells with anti-VEGF– or anti–BMP-4–neutralizing antibodies. 
In Mgp−/− epithelial cells, knockdown of Flt1 or inhibition of 
VEGF had no effect on the VEGF and c-Met expression in-
duced by BMP-4 (Fig. 6 a). In Mgp−/− ECs, however, knock-
down of Flt1 or inhibition of VEGF abolished the induction of 
HGF (Fig.  6  b). Inhibition of BMP-4 abolished induction of 
all four factors in both cell types (Fig. 6, a and b). Together, 
it suggests that BMP-4 induces VEGF and c-Met in epithelial 
cells and Flt1 in ECs. Enhanced VEGF signaling through Flt1 
then induced endothelial HGF, which has been shown to acti-
vate epithelial c-Met (Schmidt et al., 1995). Furthermore, we 
tested the effect of different concentrations of HGF on albumin 
expression in Mgp−/− pulmonary epithelial cells. The results 
show that expression of albumin increased in a dose-dependent 
manner in response to 10–30 ng/ml HGF but plateaued at HGF 
levels >30 ng/ml (Fig. 6 c). We also treated Mgp−/− pulmonary 
ECs with 300 ng/ml BMP-2, 100 ng/ml BMP-7, and 10 ng/ml 
BMP-9 for 24 h and examined the expression of VEGF, Flt1, 
Hgf, and c-Met. We found no significant induction in these fac-
tors, suggesting specificity of BMP-4 and MGP in the inter-
action between pulmonary epithelium and endothelium (Fig. 6, 
d–f). Consequently, MGP is able to regulate communication 
between the epithelium and endothelium by suppressing HGF 
through inhibition of BMP-4 activity (Fig. 6 g, working model).
Mgp−/− ECs induce albumin expression in 
Mgp−/− airway progenitor cells
Because albumin was expressed in the Nkx2.1+Sox9+FoxP2+ 
airway progenitor cells, we hypothesized that dysregulated in-
teractions between endothelium and epithelium allow hepatic 
differentiation in these progenitors. We tested the hypothesis 
using airway progenitor cells with and without the inclusion of 
ECs in a strategy schematically shown in Fig. 7 a.
First, we used WT and Mgp−/− embryonic stem cells 
(ESCs; Yao et al., 2016) to derive definitive endoderm and 
lung progenitors using previously published protocols (Mou et 
al., 2012; Lee et al., 2014). The expression of the endoderm 
markers EpCAM, c-kit, and CXCR4, as determined by flow 
cytometry, indicated that a small population of definitive endo-
derm was derived from the Mgp−/− ESCs (Fig. 7 b). We isolated 
EpCAM+c-kit+ cells and derived them into airway progenitors 
(Mou et al., 2012), which were recognized by high expression 
of Nkx2.1, Sox9, and FoxP2 (Fig. 7 c). There was no significant 
difference in the expression of these markers between Mgp−/− 
and WT progenitors (Fig. 7 c). We also examined other lineage 
markers, including FoxN1 for thymus, Pax8 for thyroid, and 
Pax9 and Tbx1 for pharyngeal pouch endoderm, and found only 
minimal induction of these markers (Fig. 7 c). In contrast, we 
found high induction of c-Met in Mgp−/− ESC-derived endoderm, 
indicating that abnormal HGF/c-Met signaling occurred during 
the derivation of the endoderm (Fig. 7 g). The results supported 
the possibility of using ECS-derived airway progenitors to test 
our hypothesis. We then labeled the Mgp−/− and WT ESCs with 
albumin promoter–driven mCherry for hepatic tracing.
We introduced two types of ECs into the derivation of air-
way progenitor cells, ESC-derived ECs (Yao et al., 2016) and 
yolk sac –derived EC line C166 (Wang et al., 1996). We infected 
Mgp−/− and WT ESCs with a lentiviral vector containing Flk1 
promoter–driven EGFP. We derived ESCs into ECs and isolated 
EGFP+ ECs by flow cytometry. Expression of the endothelial 
in the lungs of Mgp−/− mice. (h) 5-bromo-4-chloro-3-indolyl-β-d-galactopyranoside (X-gak) staining of lungs of AlbCreRosaLacZMgp+/+ and AlbCreRosaLaczMgp−/− 
mice (n = 3). (i) Schematic diagram of strategy for detecting albumin promoter–driven expression of EGFP in the lungs of Mgp−/− mice. (j) EGFP-positive 
cell populations in cells isolated from lungs of AlbCreRosaeGfpMgp+/+ and AlbCreRosaEGFPMgp−/− mice were assessed by flow cytometric analysis (n = 3). (k) 
Pulmonary function of Mgp−/− mice (n = 4). CO2, hypercapnia phase with 7% CO2, 21% O2, and balanced N2. RA, room air. (l) Expression of pulmonary 
markers in lungs of Mgp−/− mice. Mgp+/+ lung was used as control (n = 6). (m) Expression of albumin in lungs, artery, brain, kidneys, bone, heart, muscle, 
and liver in Mgp−/− mice. Mgp+/+ was used as control (n = 6). Data in c–f and k–m were analyzed by two-sided t test. **, P <0.005; ***, P < 0.001. Error 
bars are standard deviation. Data distribution was assumed to be normal, but this was not formally tested. Bars, 1 mm.
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markers VE-cadherin, von Willebrand factor, and CD31 and 
GFP expression driven by Flk1 promoter were verified in these 
ECs (Fig.  7, d and e). C166 ECs were used as control cells. 
We infected the C166 EC line with lentiviral vectors containing 
EGFP and MGP siRNA and selected EGFP-positive cells with 
≥95% of MGP mRNA knockdown (not depicted). We exam-
ined the time course of MGP expression during derivation of 
ECs and definitive endoderm from ESCs. Induction of MGP 
occurred in both processes, but the MGP level in the defini-
tive endoderm was higher than that in the ECs (Fig. 7  f). We 
examined expression of HGF, Flt1, and c-Met in both types 
of ECs and found induction of HGF and Flt1, but not c-Met 
(Fig. 7, g and h). Subsequently, we included EGFP-labeled ECs 
into the derivation of airway progenitors from ESC-derived 
endoderm and examined the expression of albumin at the end 
of the derivation. We observed that co-culture of Mgp−/− ECs 
with Mgp−/− endoderm resulted in high induction of albumin 
(Fig. 7 i), and albumin was only detected in the airway progen-
itor cells (Fig. 7  j). No induction of albumin was detected in 
the co-cultures of Mgp+/+ ECs with Mgp+/+ endoderm, Mgp+/+ 
ECs with Mgp−/− endoderm, or Mgp−/− ECs with Mgp+/+ endo-
derm (Fig. 7, i and j). We then treated the co-cultures with an-
ti-Flt1– or anti-HGF–neutralizing antibodies, which diminished 
the induction of albumin (Fig. 7 i), suggesting that the induc-
tion of albumin resulted from the induction of Flt1 and HGF in 
the Mgp−/− ECs. We repeated the co-culture experiments with 
C166 ECs and ESC-derived endoderm with similar results: only 
MGP-depleted C166 induced albumin expression in Mgp−/− air-
way progenitors (Fig.  7, k–m). The results indicated that the 
induction of endothelial HGF after activation by VEGF and Flt1 
induced hepatic differentiation in pulmonary epithelium.
Induced Hnf4a interacts with Foxa2 in 
Mgp−/− lungs
To investigate possible factors involved in the ectopic hepatic 
differentiation in Mgp−/− lungs, we examined the transcription 
factors Foxa2, Hnf4a, and Nkx2.1. Hnf4a and Foxa2 are known 
to interact (Wallerman et al., 2009) and convert mouse embry-
onic and adult fibroblasts into hepatocyte-like cells (Sekiya and 
Suzuki, 2011). Nkx2.1 and Foxa2 interact in lung epithelial 
cells and are associated with the repression of lung adenocar-
cinoma metastasis (Snyder et al., 2013; Li et al., 2015). We hy-
pothesized that abnormally expressed Hnf4a in Mgp−/− lungs 
interferes with the binding between Nkx2.1 and Foxa2, allow-
ing competitive binding between Hnf4a and Foxa2 to induce 
hepatic differentiation. To test this hypothesis, we first exam-
Figure 2. Expression of MGP, pulmonary endothelial and epithelial makers, and hepatic markers in Cd31+ and CD31− pulmonary cells of Mgp+/+ and 
Mgp−/− mice. (a) Expression of MGP in embryonic lung from E12.5 to E18.5 (n = 5). (b) Expression of MGP in CD31+ and CD31− cells isolated from lung 
and liver (n = 3). (c) Relative gene expression in CD31+ and CD31− cells isolated from lung and liver in Mgp+/+ and Mgp−/− mice (n = 3). (d) Expression of 
MGP in liver at E18.5 was analyzed by two-sided t test. ***, P < 0.001. Error bars are standard deviation. Data distribution was assumed to be normal, 
but this was not formally tested. Bars, 50 µm.
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ined these factors in Mgp−/− lungs. Compared with WT, Hnf4a 
was highly induced in Mgp−/− lungs (Fig. 8 a), whereas Nkx2.1 
and Foxa2 were not (Fig. 8 a). We then tested whether Hnf4a 
binds to Foxa2 in Mgp−/− lungs. Lysates of WT and Mgp−/− 
lungs were immunoprecipitated with anti-Foxa2 antibodies and 
analyzed by immunoblotting using anti-Hnf4a and anti-Nkx2.1 
antibodies, respectively. The results revealed binding between 
Hnf4a and Foxa2 in Mgp−/− lungs, but not in WT lungs, sug-
gesting that this interaction leads to ectopic hepatic differentia-
tion in the lungs (Fig. 8 b). The results also showed that Nkx2.1 
Figure 3. Hepatic differentiation occurs in the epithelium of Mgp−/− lungs. (a) Analysis of albumin and AFP-positive cells in Mgp−/− lungs (n = 3). (b) Gene 
expression involved in hepatic, pulmonary, or endothelial differentiation was determined in albumin and AFP–double-positive cells in Mgp−/− lungs by 
real-time PCR. Negative cells were used as controls. Data were analyzed by two-sided t test. ***, P < 0.001. Error bars are standard deviation. Data dis-
tribution was assumed to be normal, but this was not formally tested. (c) Costaining of albumin (red) and airway progenitor markers Sox9 or Foxp2 (green) 
in WT (Mgp+/+) and Mgp−/− E12.5 lungs (n = 5). (d) Costaining of albumin (red) and type I epithelial cell marker aquaporin 5 (Aqp5), type II epithelial cell 
marker surfactant protein B (Spb), or CCSP in Mgp+/+ and Mgp−/− lungs on P28 (n = 5). (e) Schematic diagram of the differentiation of albumin-positive 
cells in Mgp−/− lungs. Bars, 50 µm.
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bound to Foxa2 in both Mgp−/− and WT lungs, and the binding 
in Mgp−/− lungs was less than in WT, suggesting that Hnf4a may 
compete with Nkx2.1 for binding to Foxa2 (Fig. 8 b). To deter-
mine whether interactions between Hnf4a and Foxa2 activate 
hepatic differentiation, we performed chromatin immunopre-
cipitation (ChIP) assays to examine the albumin locus in Mgp−/− 
lungs using anti-Hnf4a and anti-Foxa2 antibodies. We found 
strong binding of Hnf4a and Foxa2 to the two Hnf4a-binding 
sites in albumin promoter in lysates of Mgp−/− lungs but not in 
WT controls (Fig.  8, c–e). The Ttr and Pax8 gene promoters 
were used as positive and negative controls, respectively (Fig. 
S4; Odom et al., 2004). To determine whether the binding of 
Hnf4a and Foxa2 affects the transcription state of albumin, 
we used ChIP assays to assess the balance of bivalent marker 
methylation of histone H3 lysine 4 (H3K4me3) and histone H3 
lysine 27 (H3K27me3) around the Hnf4a-binding site in Mgp−/− 
lungs. We observed an increase of H3K4me3, which allows 
gene activation, and a decrease of H3K27me3, which silences 
genes, supporting transcriptional activation of the albumin gene 
(Fig. 8 f). We also transfected Mgp−/− epithelial cells with a lu-
ciferase construct driven by the albumin promoter and siRNA 
for Hnf4a or Foxa2. We found that luciferase activity was ele-
Figure 4. Expression of endothelial HGF 
in embryonic lungs. (a) Costaining of HGF 
with CD34 in Mgp+/+ and Mgp−/− embry-
onic lungs from E12.5 to E18.5 (n = 5). (b) 
Costaining of HGF with Nkx2.1 in Mgp+/+ 
and Mgp−/− embryonic lungs from E12.5 to 
E18.5 (n = 5). Bars, 50 µm.
JCB • Volume 216 • NumBer 10 • 20173376
Figure 5. Decrease of HGF in ECs reduces hepatic differentiation in Mgp−/− lungs. (a) Schematic diagram of breeding strategy to create Chd5Cre 
Hgf flox/floxMgp−/− mice. (b) Genes involved in liver metabolism, with extraction of significant difference in expression (P < 0.05) derived from the gene 
expression profiles from lungs and liver of Cdh5CreHgf wt/wtMgp+/+, Cdh5CreHgf flox/flox Mgp+/+, Cdh5CreHgf wt/wt Mgp−/−, and Cdh5CreHgf flox/flox Mgp−/− mice 
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vated in Mgp−/− pulmonary epithelial cells and that Hnf4a or 
Foxa2 siRNA abolished this increase (Fig. 8 g). Together, the 
results suggest that the interaction between Hnf4a and Foxa2 
activates hepatic differentiation in Mgp−/− lungs.
Hnf4a is known to be induced by HGF during liver de-
velopment (Chen et al., 2005; Hasuike et al., 2005). To de-
termine whether endothelial depletion of HGF affects Hnf4a, 
we examined the expression of Hnf4a in the lungs of Chd5Cre 
Hgf flox/floxMgp−/− by immunoblotting. The results revealed a re-
duction of Hnf4a (Fig.  8  h), suggesting that the depletion of 
HGF abolished abnormal induction of Hnf4a in Mgp−/− lungs. 
We also analyzed lung lysates of Chd5CreHgf flox/floxMgp−/− mice 
by immunoprecipitation with anti-Foxa2 antibodies. There was 
no binding between Hnf4a and Foxa2 in the Chd5CreHgf flox/flox 
Mgp−/− mice, and binding between Foxa2 and Nkx2.1 did not 
differ between WT and Chd5CreHgf flox/floxMgp−/− mice (Fig. 8 i). 
The results suggested that limiting Hnf4a by depletion of HGF 
in ECs abolished the binding between Hnf4a and Foxa2 and 
reduced ectopic hepatic differentiation in the lungs of Chd5Cre 
Hgf flox/floxMgp−/− mice (Fig. 8 j). Collectively, our data suggest 
that cross talk between pulmonary ECs and epithelial cells is 
essential for directing pulmonary differentiation and that timely 
MGP expression is critical to prevent hepatic differentiation 
during lung development.
Discussion
In this study, we identify a critical step in which MGP is required 
for epithelial–endothelial interactions that are instrumental in 
suppressing ectopic hepatic differentiation in developing pul-
monary epithelium. Mgp gene deletion caused a mixed pulmo-
nary and hepatic differentiation in Mgp−/− lungs caused by the 
loss of BMP inhibition normally provided by MGP, most likely 
during the pulmonary specification from the foregut. Loss of 
BMP inhibition disrupts inductive effects of the endothelium 
that are necessary to differentiate the pulmonary epithelium.
In previous studies, we showed that BMP-4 induces ex-
pression of the activin receptor–like kinase 1 (ALK1), which 
is activated by BMP-9 to induce MGP (Yao et al., 2006). MGP 
then provides feedback inhibition to BMP through direct pro-
tein–protein interactions (Yao et al., 2008) and efficiently 
regulates BMP-4 activity in both pulmonary epithelium and 
vascular endothelium (Yao et al., 2011). BMP-4 is an essen-
tial early driver of EC differentiation and lung development, 
and the regulation of BMP-4 activity by MGP is critical for 
the coordination between the vasculature and airways (Yao et 
al., 2007). In this study, we examine the time course of MGP 
expression during derivation of ECs and lung endoderm from 
ESCs. We find that the induction of MGP occurs in both pro-
cesses, but to a higher level in the lung endoderm than in the 
ECs (Fig.  7  f). Thus, we show that loss of MGP has a per-
missive effect on BMP-4 activity and allows it to induce Flt1 
in the endothelium and VEGF and c-Met in the epithelium. 
VEGF then activates Flt1 to induce HGF, which elicits its ef-
fect through c-Met to cause hepatic differentiation in Mgp−/− 
pulmonary progenitor cells. This emphasizes the balance 
between BMP-4 and MGP as an agonist and suggests that it is 
sufficient to remove an antagonist to achieve changes in dif-
ferentiation. It is also noteworthy that both endothelium and 
epithelium need to be depleted of MGP to trigger the hepatic 
differentiation because MGP acts in the extracellular space. 
Altogether, the results suggest that, in early lung development, 
MGP regulates BMP-4 activity in cross talk between pulmo-
nary epithelium and vascular endothelium to direct pulmonary 
specification. We also examined the activity of other BMPs to 
determine whether our findings were specific for BMP-4. We 
found that excess BMP-2, -7, and -9 had no effect on the ex-
pression of VEGF, Flt1, HGF, and c-Met in pulmonary endo-
thelium, suggesting that the excess BMP-4 activity is driving 
the hepatic differentiation in Mgp−/− lungs.
Inductive effects of vascular endothelium have been 
shown to play key roles in developmental processes during or-
ganogenesis, including pulmonary and hepatic differentiation 
(Stainier et al., 1995; Matsumoto et al., 2001; Lee et al., 2014). 
Because the lungs and liver emerge in close proximity from the 
foregut endoderm (Herriges and Morrisey, 2014; Miyajima et 
al., 2014), the local environment, which is composed of extra-
cellular proteins, is critical for specifying the differentiation. 
ECs release BMPs in response to several stimuli (Sorescu et 
al., 2003; Csiszar et al., 2006; Boström et al., 2011), and the 
BMP distribution constitutes a key factor in lung development 
(Bellusci et al., 1996; Weaver et al., 2000). It is possible that 
expression of MGP, which begins around the emergence of the 
lung bud (Gilbert and Rannels, 2004), controls BMP activity 
in the regulation of endothelial-inductive effects that promote 
airway progenitor cells and suppress hepatic differentiation.
Although we find that HGF acts as a key factor in the ab-
normal hepatic differentiation in Mgp−/− lungs, participation 
of other extracellular factors, BMP-4 in particular, is essential. 
BMP-4 has been used as an initiating factor in the derivation 
of hepatocytes from ESCs or hepatic progenitor cells (Gouon- 
Evans et al., 2006; Fan et al., 2009). The expression of MGP is 
minimal in liver (Yao et al., 2016), and loss of MGP has no clear 
effect on the liver (Luo et al., 1997). However, there is evidence 
that other BMP inhibitors, such as Noggin, are involved in he-
patic specification (Matsumoto et al., 2001). Excess Noggin 
inhibits hepatic differentiation induced by BMP-4 (Matsumoto 
et al., 2001), suggesting that hepatic Noggin may play a role in 
the interactions between hepatic endothelium and hepatocytes.
Foxa2 is an important factor for the development of endo-
derm-derived organs, such as liver, lungs, pancreas, and stom-
ach (Nagy et al., 1994; Kimura et al., 1996; Zhou et al., 1997; 
Wan et al., 2005; Kaestner, 2010). In adult lungs, Foxa2 is de-
tected in the bronchiolar epithelium and alveolar type II cells 
(Besnard et al., 2004). It functions as a key factor in alveolar-
ization during lung development (Wan et al., 2005) but is also 
critical for the hepatic development (Lee et al., 2005; Bochkis et 
al., 2009). The interaction between Foxa2 and the lung-specific 
factor Nkx2.1 occurs in the pulmonary epithelium, and their co-
operation represses metastasis of pulmonary adenocarcinoma 
(Snyder et al., 2013; Li et al., 2015). Furthermore, collaboration 
between Foxa2, Hnf4a, and other factors drives adult fibroblasts 
and ESCs into hepatocyte-like cells (Sekiya and Suzuki, 2011; 
(n = 2). (c) Expression of albumin (Alb), Ttr, Pah, and AFP was determined in lungs by real-time PCR (n = 3). (d) The total amount of albumin (right) and 
activity of P450 (left) was determined in cells isolated from lungs (n = 8). Data in c and d were analyzed by two-sided t test. ***, P < 0.001. Error bars 
are standard deviation. Data distribution was assumed to be normal, but this was not formally tested.
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Du et al., 2014). Here, we show that Hnf4a is induced by HGF 
and binds to Foxa2 in Mgp−/− lungs to initiate hepatic differ-
entiation. Thus, Foxa2 and Hnf4a may work together to cause 
ectopic hepatic differentiation in nonliver organs, and BMP 
inhibition appears essential for suppression of Hnf4a during 
pulmonary differentiation. However, the binding of Hnf4a and 
Foxa2 competes with that of Foxa2 and Nkx2.1 and could affect 
lung development through this mechanism.
Our observation differs from reported cases of ectopic 
liver tissues in human lungs (Hudson and Brown, 1962; Lasser 
and Wilson, 1975; Mendoza et al., 1986; Iber and Rintala, 
1999; Chalak and Parham, 2007; Choi et al., 2008; Tancredi 
et al., 2010; Bannon et al., 2013). In Mgp−/− mouse, the lungs 
still develop and function, although the alveolar structures and 
pulmonary vasculature are abnormal. In contrast, the reported 
ectopic liver tissue in the lungs does not resemble pulmonary 
tissue and may result from translocation of hepatocytes into the 
lungs because of unknown reasons. Interestingly, peptidomics 
of bronchoalveolar lavage fluid from premature neonates with 
bronchopulmonary dysplasia reveal high concentrations of 
albumin fragments that could not be ascribed to an enhanced 
diffusion of albumin from serum (Vento et al., 2009). It is pos-
sible that it could be an indication of abnormalities involving 
enhanced BMP signaling.
Figure 6. Cross talk between endothelial and epithelial cells induces HGF in Mgp−/− lungs. (a and b) Epithelial cells (a) and ECs (b) isolated from Mgp+/+ 
and Mgp−/− lungs were treated with BMP-4, anti-VEGF or anti–BMP-4 (a-BMP-4) antibodies, or transfected with Flt1 siRNA. Expression of VEGF, Flt1, HGF, 
and c-Met was determined by real-time PCR after 24 h of treatment (n = 3). (c) Expression of albumin (Alb) in epithelial cells was isolated from Mgp+/+ and 
Mgp−/− lungs and treated with HGF for 24 h (n = 3). (d–f) Expression of VEGF, Flt1, HGF, and c-Met in ECs was isolated from Mgp+/+ and Mgp−/− lungs 
and individually treated with BMP-2, -7, and -9 (n = 3). (g) Schematic diagram of cross talk between ECs and epithelial cells. Data in a–f were analyzed 
by two-sided t test. *, P < 0.05; **, P < 0.01; ***, P < 0.001. Error bars are standard deviation. Data distribution was assumed to be normal, but this 
was not formally tested.
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Figure 7. Albumin induced in airway progenitors derived from Mgp−/− ESCs when co-cultured with Mgp−/− ECs. (a) Schematic diagram of the experimen-
tal strategy. KDR, kinase insert domain receptor. (b) Flow cytometric analysis of EpCAM+c-kit+ and CXCR4+c-kit+ cell populations in definitive endoderm 
(DE) derived from WT (Mgp+/+) and Mgp−/− ESCs (n = 3). (c) Gene expression of lineage markers was determined by real-time PCR with normalization 
to GAP DH expression in airway progenitors derived from WT (Mgp+/+) and Mgp−/− EpCAM+c-kit+ definitive endoderm cells. Fold changes of expression 
are calculated as compared with the FoxN1 expression in Mgp+/+EpCAM+c-kit+ definitive endoderm cells (n = 3). (d) Expression of von Willebrand factor 
(vWF), CD31, and VE-cadherin in induced ECs derived from Mgp+/+ and Mgp−/− ESCs. The C166 line is shown as control (n = 3). (e) Expression of EGFP 
driven by the Flk1 promoter in C166 cells and Mgp+/+- and Mgp−/−-induced ECs (n = 5). (f) Time course of MGP expression during the derivation of EC 
and definitive endoderm from Mgp+/+ and Mgp−/− ESCs (n = 3). (g) Gene expression of HGF, Flt1, and c-Met was determined by real-time PCR in airway 
progenitors (AP) derived from Mgp+/+ and Mgp−/− EpCAM+c-kit+ definitive endoderm cells (n = 3). (h) Gene expression of HGF, Flt1, and c-Met was 
determined by real-time PCR in induced ECs derived from Mgp+/+ and Mgp−/− ESCs (n = 3). (i) Albumin expression was determined by real-time PCR in 
Nkx2.1+FoxP2+ cells derived from Mgp+/+ and Mgp−/− EpCAM+c-kit+ definitive endoderm cells with co-culture of Mgp+/+ and Mgp−/− ECs. Anti-Flt1 (a-Flt1) 
and anti-HGF (a-HGF) were added to neutralize Flt1 and HGF, respectively (n = 3). (j) EGFP and mCherry were determined in the co-culture of airway 
progenitors and ECs by fluorescence microscopy (n = 4). BF, bright field. (k) Gene expression of HGF, Flt1, and c-Met was determined by real-time PCR in 
C166 ECs transfected with scrambled siRNA (SCR) or MGP siRNA (si) (n = 3). (l) Albumin expression was determined by real-time PCR in Nkx2.1+FoxP2+ 
cells derived from Mgp+/+ and Mgp−/− EpCAM+c-kit+ definitive endoderm cells with co-culture of MGP-depleted C166 ECs. a-Flt1 and a-VEGF were added 
to neutralize Flt1 and VEGF, respectively (n = 3). (m) EGFP and mCherry were determined by fluorescence microscopy in airway progenitors derived from 
Mgp−/− EpCAM+c-kit+ definitive endoderm cells with co-culture of C166 ECs (n = 5). Data in c and d, f–i, and k and l were analyzed by two-sided t test. 
**, P < 0.01; ***, P < 0.001. Error bars are standard deviation. Data distribution was assumed to be normal, but this was not formally tested. Bars, 50 µm.
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Altogether, our results support a critical role for BMP 
inhibition, as provided by MGP, in epithelial–endothelial in-
teractions between vascular endothelium and pulmonary epi-
thelium to prevent hepatic differentiation from occurring during 
pulmonary specification.
Materials and methods
Animals
Mgp+/− (B6.129S7-Mgptm1Kry/KbosJ), Cdh5Cre (B6.Cg-Tg(Cdh5- 
cre)7Mlia/J), AlbCre (B6.Cg-Tg(Alb-cre)21Mgn/J), RosaLacZ (B6; 
Figure 8. HGF-induced Hnf4a binds to Foxa2 in 
Mgp−/− lungs. (a) Expression of Hnf4a, Nkx2.1, 
and Foxa2 was determined in lungs by real-time 
PCR (n = 5). Liver of WT mice was used as a con-
trol. (b) Protein interactions in lung lysates were 
analyzed by immunoprecipitation (IP), followed 
by immunoblotting (IB) with antibodies as indi-
cated (n = 6). Lysates from WT Mgp+/+ liver were 
used as a positive control. (c–f) Hnf4a and Foxa2 
bind to the albumin locus at the Hnf4a-binding 
site and alter the albumin transcription state in 
Mgp−/− lungs, as detected by ChIP assays (n = 
3). (g) Luciferase assay of pulmonary epithelial 
cells integrated with luciferase reporter driven 
by the albumin promoter and transfected with 
scrambled siRNA (SCR), Hnf4a siRNA, or Foxa2 
siRNA (n = 3). (h) Expression of Hnf4a was deter-
mined in lungs of Cdh5CreHgfwt/wtMgp+/+, Cdh5Cre 
Hgf flox/floxMgp+/+, Cdh5CreHgfwt/wtMgp−/−, and 
Cdh5CreHgf flox/floxMgp−/− mice by immunoblotting. 
WT Mgp+/+ liver was used as a control (n = 3). 
(i) Protein interactions of lung lysates were ana-
lyzed by immunoprecipitation, followed by immu-
noblotting with antibodies as indicated (n = 6). 
Lysates from WT Mgp+/+ liver were used as a pos-
itive control. (j) Schematic diagram of the binding 
of Hnf4a and Foxa2 competing with that of Foxa2 
and Nkx2.1 in Mgp−/− lungs. Data in a and d–g 
were analyzed by two-sided t test. *, P < 0.05; 
***, P < 0.001. Error bars are standard devia-
tion. Data distribution was assumed to be normal, 
but this was not formally tested.
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129S4-Gt(ROSA)26Sortm1Sor/J), and RosaeGfp (B6;129-Gt(ROSA) 
26Sortm2Sho/J) mice on a C57BL/6J background were obtained from 
the Jackson Laboratory. Hgf flox/flox (B6;129-Hgftm1Jmw/Mmnc) mice 
were obtained from the Mutant Mouse Resource and Research Cen-
ter. Genotypes were confirmed by PCR (Yao et al., 2012), and experi-
ments were performed with generations F4–F6. Littermates were used 
as WT controls. All mice were fed a standard chow diet (Diet 8604; 
HarlanTeklad Laboratory). The studies were reviewed and approved 
by the Institutional Review Board and conducted in accordance with 
the animal care guidelines set by the University of California, Los An-
geles. The investigation conformed to the standards of the National 
Research Council (2011).
Maintenance and differentiation of ESCs
E14.1 mouse ESCs (C57BL/6J background) were obtained from the 
American Type Culture Collection (SCRC-1002) and used as WT 
ESCs in this study. Before induction of differentiation, ESCs were 
cultured in Glasgow minimum essential medium (Invitrogen) con-
taining 10% knockout serum replacement (Invitrogen), 1% FBS 
(HyClone), 1% penicillin/streptomycin/glutamine, 1% nonessential 
amino acids (Invitrogen), 0.1 mM 2-mercaptoethanol, 1 mM sodium 
pyruvate, and 1,000 U/ml leukemia inhibitory factor (ESG RO). The 
medium was changed daily.
The protocol adopted for lung differentiation was performed as 
previously described (Mou et al., 2012). The ESCs were trypsinized, 
quenched with FBS, centrifuged, and plated onto gelatin-coated dishes 
for murine embryonic fibroblast depletion for 30 min. ESCs were sub-
sequently cultured at a density of 5–8 × 103 cells/cm2 in day 0 medium 
(advanced DMEM with 2% B-27 minus vitamin, 0.05% Albumax II, 
Glutamax, and Y-27632). On day 2, the cells were placed with day 2 
differentiation medium (advanced DMEM with 2% FBS, Glutamax, 
5 nM GSK3iXV, and 50 ng/ml activin A; 338-AC; R&D Systems). On 
day 3, the cells were fed with day 2 medium, 50 ng/ml activin A, and 
5 M dorsomorphin (P5499; Sigma-Aldrich). To anteriorize endoderm, 
on and after day 5, the cells were split and fed with day 0 medium and 
0.5–1 mM A8301 (616454; CalBiochem) for 2 d. Then, the cells were 
rinsed with day 0 medium two times and switched to day 0 medium 
supplemented with 50 ng/ml BMP-4, 100 ng/ml FGF-2 (PHG0026; 
GIB CO), and 5–10 nM GSK3iXV for another 2–3 d. To generate Nkx-
2.1+Sox2+ proximal progenitor cells, the cells were rinsed with day 0 
medium two times and switched to day 0 medium containing retinoic 
acid–supplemented B-27, 50 ng/ml BMP-7, 50 ng/ml FGF-7, 100 nM 
IWR-1, and 1–2 mM PD98059 for 2 d or longer.
EC differentiation was performed as previously described (Israely 
et al., 2014). The differentiation of ESCs was performed in serum-free 
media (StemPro-34; Invitrogen), reconstituted according to the man-
ufacturer’s instructions, and supplemented with 1× l-glutamine, 1× 
β-mercaptoethanol, 0.5 mM ascorbic acid (Millipore), and 200 µg/ml 
bovine holotransferrin (Sigma-Aldrich). Differentiation of ESCs was 
performed in 10-cm nontissue culture-treated Petri dishes for 14 d, fol-
lowed by adherent culture on gelatin-coated 6-well plates in a humid-
ified incubator at 37°C with 5% CO2. On day 1, 5 ng/ml BMP-4 was 
added. On day 2, the media were supplemented with 5 ng/ml of fresh 
BMP-4, 5 ng/ml activin A, and 10 ng/ml FGF-2. On day 3, the media 
were supplemented with 5 ng/ml of fresh BMP-4, 10 ng/ml FGF-2, and 
20 ng/ml VEGF-A. On day 5, the media were supplemented by adding 
10 ng/ml of fresh FGF-2 and 20 ng/ml VEGF-A. The media were then 
refreshed every 2 d with 5 ng/ml FGF-2 and 5 ng/ml VEGF-A.
For co-culture, the day 7 anteriorized definitive endoderm cells 
from both WT and Mgp knockout ESCs were dissociated, and the Ep-
CAM+c-kit+ cells were isolated by FACS and subsequently plated on gel-
atin-coated dishes in Nkx2.1 induction media. The co-culture endothelial 
partner cells included CD31+KDR+cells sorted on day 7 of endothelial 
differentiation in ESCs, mouse yolk sac EC C166 (CRL-2581; Amer-
ican Type Culture Collection) with or without MGP expression, and 
adult mouse lung ECs with or without MGP sorted by EGFP from Cdh5- 
EGFP-Mgp+/+ and Cdh5-EGFP-Mgp−/− mice. The EpCAM+c-kit+ cells 
were co-cultured with EC counterparts at a ratio of 1:1, i.e., 50,000:50,000 
cells per well of a 48-well plate. Inhibition of Flt1 and HGF was per-
formed by adding 2 µg/ml Flt1- or HGP-neutralizing antibodies (R&D 
Systems) every other day starting on day 7. 1 µg/ml of the isotype IgG 
or 5 mM DMSO (Sigma-Aldrich) was added to the media as controls.
Expression profiles
Total mRNA was extracted from aortic tissues and examined by the 
MouseRef-8 v2.0 BeadChip kit (Illumina). The array data were an-
alyzed using GenomeStudio software (Illumina). The expression 
profiles were extracted from array data, and the heat map was gener-
ated using GenomeStudio.
RNA analysis
Total RNA was extracted from cells and tissues using the RNeasy mini 
or micro kit (Qiagen). cDNA was produced by using the high-capacity 
cDNA reverse transcription kit (Applied Biosystems) according to the 
manufacturer’s instructions. Relative quantitative PCR was performed 
on a 7500 Fast Real-Time PCR System (Applied Biosystems) using 
TaqMan Universal PCR Master Mix (Applied Biosystems). Cycle con-
ditions were one cycle at 50°C for 2 min, one cycle at 95°C for 10 min, 
and then 40 cycles at 95°C for 15  s and 60°C for 1 min. Threshold 
cycles of specific cDNAs were normalized to the housekeeping gene 
GAP DH and translated to relative values. The TaqMan for mouse albumin 
(Mm00802090_m1), Ttr (Mm00443266_m1), Pah (Mm00500918_
m1), GATA4 (Mm00484689_m1), Foxa3 (Mm00484714_m1), Hnf1a 
(Mm00493434_m1), Hnf4a (Mm01247712_m1), AFP (Mm00431715_
m1), Hex (Mm00599877_m1), HGF (Mm01135184_m1), Apof 
(Mm00506066_g1), Apod (Mm01342307_m1), Apoe (Mm01307193_
g1), Apoc1 (Mm00431816_m1), Apoa1 (Mm00437569_m1), 
Apom (Mm00444525_m1), Apoh (Mm00496516_m1), Apoa2 
(Mm00442687_m1), Apoc4 (Mm00545713_m1), Apoc3 
(Mm00445670_m1), Apoa5 (Mm00475480_m1), Apoa4 
(Mm00431814_m1), Nkx2.1 (Mm01702813_m1), Flt1 (Mm00438980_
m1), FoxN1 (Mm00433948_m1), Pax9 (Mm00440629_m1), Tbx1 
(Mm00448949_m1), Pax8 (Mm00440623_m1), Sox9 (Mm00448840_
m1), FoxP2 (Mm00475030_m1), c-Met (Mm01156972_m1), 
VEGF (Mm00437306_m1), Aqp5 (Mm00437578_m1), CCSP 
(Mm00442046_m1), Spd (Mm00445061_m1), Spc (Mm00488144_
m1), Spb (Mm00455678_m1), Flk1 (Mm01222421_m1), VE- 
cadherin (Mm00486938_m1), CD31 (Mm01242576_m1), and Foxa2 
(Mm01976556_s1) was obtained from Applied Biosystems as part of 
TaqMan gene expression assays.
Immunofluorescence
Tissue sections were fixed in 4% paraformaldehyde and processed as 
previously described (Yao et al., 2016). For immunohistochemistry or 
immunofluorescence, sections were permeabilized with 0.5% Triton 
X-100 for 10 min, followed by three washes with wash buffer (WB; 
PBS containing 0.1% Tween 20). Nonspecific antibody-binding sites 
were blocked by incubating the sections for 30 min in blocking buf-
fer (1% BSA, 2% goat serum, and 0.5% Triton X-100 in PBS). Pri-
mary antibodies were diluted in antibody buffer (1% BSA and 0.5% 
Triton X-100) in PBS, and sections were incubated for 60 min at 
room temperature, followed by several washes in WB. Alexa Fluor 
(AF) 488–conjugated (green fluorescence) or AF594-conjugated (red 
fluorescence) secondary anti–goat or anti–rabbit antibodies (Molecu-
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lar Probes) were applied to the sections and incubated for 30 min at 
room temperature. After several washes in WB and a brief equilibra-
tion of the sections with PBS, the nuclei were stained with DAPI (Sig-
ma-Aldrich). A DAPI stock solution was diluted to 300 nM in PBS, 
and 300 µl of the diluted solution was added to the sections, making 
certain that they were completely covered. The samples were incu-
bated for 1–5 min and rinsed several times in PBS. Staining without 
primary antibodies served as controls. We used specific antibodies for 
Sox9 (mouse ab76997; Abcam), Foxp2 (rabbit ab16046; Abcam), al-
bumin (goat A90-134A; Bethyl), Aqp5 (rabbit 178615; Millipore), Spb 
(mouse ab3282; Abcam), CCSP (rabbit 07–623; Millipore), Nkx2.1 
(rabbit ab40874; Abcam), MGP (rabbit ab86233; Abcam), HGF (goat 
AF2207; R&D Systems), and CD34 (rat 551387; BD Biosciences).
Flow cytometric analysis
The cells were detached from the culture dish with 0.25% trypsin/
EDTA, centrifuged at low speed, and stained with FITC-, phycoeryth-
rin (PE)-, or AF488-conjugated antibodies. Nonspecific fluorochrome- 
and isotype-matched IgGs (BD PharMingen) served as controls. Flow 
cytometer gates were set using unstained cells and the isotype-matched 
controls. Cells were gated by forward scatter versus side scatter to 
eliminate debris. A region was established to define positive PE/AF488 
fluorescence using a PE/AF488-conjugated, isotype-specific control. 
The number of cells stained positive for a given marker was determined 
by the percentage of cells present within a gate, which was established 
such that <2% of positive events represented nonspecific binding by the 
PE/AF488-conjugated, isotype-specific control. Minimums of 10,000 
events were counted for each analysis. All FACS analyses were per-
formed using a flow cytometer (LSR II; BD Biosciences). FACS files 
were exported and analyzed using Cellquest software v.3.3 (BD). The 
cells were stained with antibodies against albumin (goat A90-134A; 
Bethyl), AFP (mouse 7741; Cell Signaling), EPC AM (rat 552370; Bec-
ton, Dickinson and Company), CXCR4 (rabbit ab2074; Abcam), and 
c-kit (BD Biosciences).
Immunoblotting and immunoprecipitation
For immunoprecipitation, anti–mouse Foxa2 antibodies (rabbit 
ab76013; Abcam) were cross-linked to Dynabeads protein G (Thermo 
Fisher). 40 μl Dynabeads was incubated with Foxa2 antibodies for 1 h 
before washing and incubation with cell extract. Dynabead–antibody 
complexes were later added to lung extracts from WT and Mgp−/− mice 
(300 µg of protein per sample) with gentle rotation at 4°C for 4 h. Beads 
were subsequently washed three times with 10 mM Tris-HCl, pH 7.5, 
and 50 mM KCl. Elution was performed by heating the beads for 10 
min at 70°C in 20  µl NuPage loading buffer (Invitrogen) containing 
100 mM DTT or SDS elution buffer (2% SDS, 100 mM Tris-HCl, pH 
7.5, 10% glycerol, 0.5 mM EDTA, 100 mM DTT, and bromophenol 
blue as tracer). After removal of the supernatant, the procedure was 
repeated, and the combined supernatants were neutralized with 2 µl of 
1 M Tris, pH 10.0. The eluates were analyzed by immunoblotting. For 
immunoblotting, equal amounts of tissue lysates were used. Blots were 
incubated with specific antibodies to Foxa2 (rabbit ab76013; Abcam), 
Hnf4a (mouse ab41898; Abcam), and Nkx2.1 (rabbit ab40874; Abcam). 
β-Actin (mouse a2228; Sigma-Aldrich) was used as a loading control.
ELI SA
The level of albumin was examined by using an ELI SA kit (Abcam). The 
assays were performed in accordance with the manufacturer’s protocols.
P450 activity
The activity of P450 was measured by a cytochrome P450 reduc-
tase activity assay kit (Abcam). Equal amounts of tissue lysates 
were measured. The assays were performed in accordance with the 
manufacturer’s protocols.
ChIP assay
For each ChIP assay, ∼106 cells were cross-linked in 1% formaldehyde 
for 10 min at room temperature. Glycine was added to a concentration 
of 0.125 M to quench the cross-linking. The cells were then rinsed with 
ice-cold PBS, resuspended and lysed in lysis buffers, and sonicated to 
shear the cross-linked DNA to fragments ranging from 200 to 500 bp 
as previously described by Collas (2010). Sonication was performed on 
a 4000 Sonicator (Misonix) while the samples were kept immersed in 
an ice water bath, and 1/10–1/20 of the sonicated lysate was saved for 
input DNA extraction. The lysate was incubated with 1 µg anti–mouse 
Hnf4a (mouse ab41898; Abcam), anti–mouse Foxa2 (rabbit ab76013; 
Abcam), anti-H3K4me3 (rabbit ab8580; Abcam), and anti-H3K27me3 
(mouse ab6002; Abcam) antibodies or normal IgG at 4°C overnight. 
After adding 40 µl protein G magnetic beads, the lysate was further 
incubated for 2–3 h. The beads were washed repeatedly, and DNA was 
eluted from the beads by incubating in 10 mM Tris-Cl, pH 8.5, for 15 
min at 65°C.  Both the immunoprecipitated and input DNA samples 
were incubated overnight at 65°C for reversal of cross-linking. The 
DNA samples were then purified by sequential phenol/chloroform/
isoamyl alcohol (Sigma-Aldrich). The final DNA products were etha-
nol precipitated, and the pellets were air dried and dissolved in 10 mM 
Tris-HCl. The following primers were used for the ChIP assay: Hnf4a 
site 1 was forward, 5′-CCA CAC TCT CTT CTC CTT CAA CC-3′, and 
reverse, 5′-ATC TCC ATT CTA CCC TCC CAG TC-3′. Hnf4a site 2 was 
forward, 5′-TGC ATT TGC CAG AAA GTG AAGA-3′, and reverse, 5′-
AAC CAG CCT CTA ATT CCC GTGT-3′. H3K4me3 and H3K27me3 
were forward, 5′-TTT AAC TCC CCG TAA CTC ATGT-3′, and reverse, 
5′-GGC AGT GAT GGT TGC ACA AG-3′.
Pulmonary function test
Mice were weighed and placed into a single chamber with a volume 
of 0.8 liters, where they were allowed to move freely and acclimate 
for at least 15 min. To provide a baseline reading, a room air reading 
was taken as follows: compressed air was supplied to the chamber at 
a flow rate of 1 liter/min for 45 min. At this point, the chamber was 
completely sealed, with airflow momentarily stopped. The changes 
in pressure caused by breathing were recorded and amplified by Fine 
Pointe. Subsequently, the mice were allowed to rest for at least 5 min 
or until the breathing returned to baseline before conducting the hyper-
capnia phase. In the hypercapnia phase, a gas mixture containing 7% 
CO2, 21% O2, and balanced N2 was supplied to the chamber at a flow 
of 1 liter/min. After 5 min, the chamber was sealed, and ventilatory 
patterns were recorded. During the room air breathing and hypercap-
nia phase, the mean tidal volume and respiratory rate were measured 
for a period of at least 10 consecutive breaths. To avoid an excessive 
build-up in CO2 concentration within the chamber caused by rebreath-
ing, a Bias flow regulator (Buxco Electronics, Inc.) was used. The Bias 
flow regulator provided a quiet, constant, and smooth flow through the 
animal chamber that prevented CO2 build-up. The following param-
eters were recorded: respiratory rate, tidal volume, peak inspiration 
flow, peak expiratory flow, and minute ventilation, which was calcu-
lated and corrected for body weight. The mean values were calculated 
once per minute for each serial 10 min. The machine was sanitized 
with alcohol between uses.
Luciferase assay and siRNA transfection
For luciferase assays, the cells were lysed in 100  µl Passive Lysis 
Buffer (Promega) per well in 24-well plates. The cells were freeze-
thawed twice and agitated for 15 min. Two 20-µl aliquots from each 
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well were used for luciferase assays (Promega). Luciferase activity 
was determined using a luminometer (AutoLumat LB953; Perki-
nElmer Life Sciences) and expressed as mean ± standard deviation 
from quadruplicate experiments. The construction, in which lucif-
erase was driven by albumin promoter, was obtained from GeneCo-
poeia (MPRM26381-PG02). Transient transfections with siRNA 
were performed with Lipofectamine 2000 (Invitrogen) using 60 nM 
siRNA. siRNAs to Hnf4a (s67635; sense: 5′-AGA GGU CCA UGG 
UGU UUA ATT-3′; antisense: 5′-UUA AAC ACC AUG GAC CUC 
UTG-3′; Thermo Fisher) and Foxa2 (s67629; sense: 5′-GAG GGC 
UAC UCU UCC GUG ATT-3′; antisense: 5′-UCA CGG AAG AGU AGC 
CCU CGG-3′; Thermo Fisher) were used for experiments. Scrambled 
siRNA was used as a control.
Fluorescence microscopy
Images were captured by a microscope (Eclipse Ti-s; Nikon) with 
digital camera (DS-Fi2; Nikon) at room temperature. Three different 
magnification objective lenses (4×, 10×, and 20×) were used, and the 
acquisition software was NIS Elements Br. AF488-conjugated (green 
fluorescence) or AF594-conjugated (red fluorescence) secondary an-
tibodies (Molecular Probes) were applied to the sections. EGFP or 
mCherry was used as tagged markers for molecules in live cells. All 
images of live cells were captured in DMEM.
Statistical analysis
A two-sided t test was used to analyze the data. The analyses were 
performed using Instat version 3.0 (GraphPad Software). Data repre-
sent mean ± standard deviation. P-values <0.05 were considered sig-
nificant, and experiments were repeated a minimum of three times. 
Data were analyzed for statistical significance by ANO VA with 
post-hoc Tukey’s analysis.
Online supplemental material
In the online supplemental material, we showed the expression of apo-
lipoproteins in Mgp+/+ and Mgp−/− lungs and examined Mgp+/+ and 
Mgp−/− lungs by using transmission EM (Fig. S1). We showed expres-
sion of pulmonary markers in the lungs and livers of Mgp+/+, Mgp−/−, 
and Mgptg/wt and Mgp−/−mice (Fig. S2). We examined the expression 
of EGFP in the lungs of AlbCreRosaEGFPMgp−/− mice and verified that 
Hnf4a binds to the Ttr gene promoter, but not the Pax8 promoter in 
Mgp−/− lungs, by using ChIP assays (Fig. S3 and Fig. S4). 
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